Diagnosing and Treating Low Blood Sugar Levels
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00001276|
Recruitment Status : Recruiting
First Posted : November 4, 1999
Last Update Posted : November 11, 2019
Hypoglycemia is the term used to refer to lower than normal levels of blood sugar. This study will continue to research the causes of hypoglycemia.
Patients involved in the study will be admitted to the Clinical Center of the National Institutes of Health and undergo tests for evaluating blood sugar. Patients will be required to refrain from eating for a set period of time and will undergo blood tests for insulin levels and several other specific diagnostic tests related to insulin secretion. The patients will be under supervision and will be provided with appropriate medical and surgical attention as needed.
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||99999999 participants|
|Official Title:||Fasting Hypoglycemia: Diagnosis and Treatment|
|Actual Study Start Date :||January 29, 1991|
Patients with hypoglycemia
Patients with hypoglycemia due to diverse etiologies.
- Treatment Outcomes [ Time Frame: every 6-12 months ]resolution of hypoglycemia
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00001276
|Contact: Phillip Gorden, M.D.||(301) firstname.lastname@example.org|
|United States, Maryland|
|National Institutes of Health Clinical Center, 9000 Rockville Pike||Recruiting|
|Bethesda, Maryland, United States, 20892|
|Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 email@example.com|
|Principal Investigator:||Phillip Gorden, M.D.||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|